Carboplatin Plus Gemcitabine for Elderly Patients With Stage IV NSCLC

NCT02175381 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

69

Enrollment

OTHER

Sponsor class

Conditions

NSCLC

Interventions

DRUG: Carboplatin
DRUG: Gemcitabine

Sponsor

Hellenic Oncology Research Group